| Patent | Date |
|---|
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20220125797 - Cohen; Benjamin M. ; et al. | 2022-04-28 |
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 11,241,439 - Cohen , et al. February 8, 2 | 2022-02-08 |
Mk2 Inhibitors, Synthesis Thereof, And Intermediates Thereto
App 20210139501 - Feigelson; Gregg Brian ; et al. | 2021-05-13 |
MK2 inhibitors, synthesis thereof, and intermediates thereto
Grant 10,894,796 - Feigelson , et al. January 19, 2 | 2021-01-19 |
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20200360395 - Cohen; Benjamin M. ; et al. | 2020-11-19 |
Isotopologues Of 5-azacytidine
App 20200316099 - Traverse; John F. ; et al. | 2020-10-08 |
Processes For The Preparation Of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
App 20200299228 - Traverse; John F. ; et al. | 2020-09-24 |
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
Grant 10,717,703 - Traverse , et al. | 2020-07-21 |
Isotopologues of 5-azacytidine
Grant 10,646,503 - Traverse , et al. | 2020-05-12 |
Mk2 Inhibitors, Synthesis Thereof, And Intermediates Thereto
App 20200102326 - Feigelson; Gregg Brian ; et al. | 2020-04-02 |
Isotopologues Of 5-azacytidine
App 20200101095 - Traverse; John F. ; et al. | 2020-04-02 |
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
Grant 10,596,180 - Cohen , et al. | 2020-03-24 |
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions
App 20190365772 - Cohen; Benjamin M. ; et al. | 2019-12-05 |
Isotopologues of 5-azacytidine
Grant 10,463,683 - Traverse , et al. No | 2019-11-05 |
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 10,463,672 - Cohen , et al. No | 2019-11-05 |
Isotopologues Of 5-azacytidine
App 20190231803 - Traverse; John F. ; et al. | 2019-08-01 |
Processes For The Preparation Of (s)-tert-butyl 4,5-diamino-5-oxopentanoate
App 20190084924 - Traverse; John F. ; et al. | 2019-03-21 |
Isotopologues of 5-azacytidine
Grant 10,220,050 - Traverse , et al. | 2019-03-05 |
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20180200255 - Cohen; Benjamin M. ; et al. | 2018-07-19 |
Isotopologues Of 5-azacytidine
App 20180153916 - Traverse; John F. ; et al. | 2018-06-07 |
Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and pharmaceutically acceptable forms thereof
Grant 9,975,872 - Traverse , et al. May 22, 2 | 2018-05-22 |
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,884,062 - Cohen , et al. February 6, 2 | 2018-02-06 |
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20170258803 - Cohen; Benjamin M. ; et al. | 2017-09-14 |
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,629,849 - Cohen , et al. April 25, 2 | 2017-04-25 |
Processes For The Preparation Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Pharmaceutically Acceptable Forms Thereof
App 20160251333 - TRAVERSE; John F. ; et al. | 2016-09-01 |
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20160136174 - COHEN; Benjamin M. ; et al. | 2016-05-19 |
Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dion- e and pharmaceutically acceptable forms thereof
Grant 9,309,220 - Traverse , et al. April 12, 2 | 2016-04-12 |
Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dion- e and compositions comprising and methods of using the same
Grant 9,221,788 - Cohen , et al. December 29, 2 | 2015-12-29 |
Processes for preparing isoindoline-1,3-dione compounds
Grant 9,133,161 - Traverse , et al. September 15, 2 | 2015-09-15 |
Isotopologues Of 5-azacytidine
App 20150056280 - TRAVERSE; John F. ; et al. | 2015-02-26 |
Processes For The Preparation Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Pharmaceutically Acceptable Forms Thereof
App 20140046058 - Traverse; John F. ; et al. | 2014-02-13 |
Processes For Preparing Isoindoline-1,3-dione Compounds
App 20140031552 - TRAVERSE; John F. ; et al. | 2014-01-30 |
Process For Preparing Ccr-5 Receptor Antagonists Utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl Compounds
App 20100063280 - Traverse; John F. ; et al. | 2010-03-11 |
Hydrogels for orthopedic repair
App 20060093648 - Coury; Arthur J. ; et al. | 2006-05-04 |
Hydrogels for orthopedic repair
Grant 7,008,635 - Coury , et al. March 7, 2 | 2006-03-07 |
| 